Clinical Trial

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis under the care of a licensed dermatologist or qualified physician extender. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices. Condition or disease : Atopic Dermatitis
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-08-05; most recent amendment 2026-02-05.
Trial Details
NCT Number NCT04504955
Lead Sponsor CorEvitas
Conditions Atopic Dermatitis
Enrollment 10,000 participants
Start Date 2020-07-14
Primary Completion 2100-12 (estimated)
Study Completion 2100-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-09